OPHTHALMOLOGY MACULA DEGENERATION MBChB 4 Prof P Roux 2012.

Slides:



Advertisements
Similar presentations
Medical Retina and Macular Diseases
Advertisements

Overview Of Retinal Conditions Clinical and OCT Findings Central Coast Day Hospital Inaugural Optometrist Conference 26th February 2012 Anil Arora.
Welcome to CNIB’s InFocus Webinar Series
containing xanthophyll (yellow) pigment.
Grand Rounds Peripheral Exudative Hemorrhagic Chorioretinopathy
Choroidal neovascularisation CNV PDT,TTT,MPC ALI. SALEHI MD.
AMD DEHGHANI.A Soft drusen Classic CNV Occult CNV Fibrovascular pigment epithelium detachment Retinal angiomatous proliferation Polypoidal choroidal.
OCT OF MCULAR DISEASES DEHGHANI.A near infrared light near infrared light cross-sectional images of tissue cross-sectional images of tissue High resolution)
Central Serous Chorioretinopathy rare but typical changes Dr Edi Ladavac Department of Ophthalmology General Hospital, Pula.
Ophthalmology for Finals
FOURIER DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN THE MANAGEMENT OF POSTERIOR SEGMENT DISORDERS: A REVEALING CASE SERIES OLUFEMI ODERINLO FRCSEd FWACS DRCOphth.
CENTRAL SEROUS RETINOPATHY (C.S.R)(C.S.C)
IMAGING in AMD From Fluorescein Angiography To the Spectral Domain OCT
Grand Rounds Best Disease Mark Sherman MD University of Louisville Department of Ophthalmology and Visual Sciences 04/04/2014.
Grand Rounds Shivani V. Reddy, M.D. 7/18/14 University of Louisville Department of Ophthalmology and Visual Sciences.
SAMIR AL-MANSOURI, MD. e.g. - cataract - glaucoma - macular degeneration - diabetic retinopathy Chronic = slowly progressive visual loss Major causes:
Age-Related Macular Degeneration
AGE RELATED MACULAR DEGENERATION
AMD & Treatment Options
Juvenile Macular Degeneration
Age Related Macular Degeneration Bethan. Epidemiology Most common cause irreversible visual loss in >50yrs 10% > 65-74yrs 30% > 75yrs Prevalence increasing.
Age-Related Macular Degeneration
Clinical Trials in Ophthalmology
FFA Dr Aaron Ng. FFA Principles Fluorescence – Stimulated by light of shorter wavelength – Emission of light of longer wavelength Flurescein – Excitation.
AGE RELATED MACULAR DEGENERATION. An epidemic of “ageing” is impending in the Western world. According to the latest predictions released by the United.
MACULAR DEGENERATION Macular Degeneration Types: -Atrophic (age-related) :dry -Exudative :wet Populations at Risk: Greater than 60 yrs. Old Females >
Macular Degeneration A.M.D WHAT IS IT? A.M.D. - Age-related macular degeneration is a painless eye condition that leads to the gradual loss of central.
Beginning of the chapter Macular degeneration and Genetics (AMD Sensor) 32.
1 Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trial (CATT) Jaffe GJ, Martin DF, Toth CA, Daniel.
Mahmood J Showail 11/03/2009. A 17 -year-old high school female student presented to our clinic with history of sudden decrease of vision in her left.
AGE RELATED MACULAR DEGENERATION. AMD epidemic of aging Prediction by United Nations 606 million over age 60 in 2000 will go to 2 billion by 2050 Population.
Gene Transfer for Neovascular Age- Related Macular Degeneration Peter A. Campochiaro The Wilmer Eye Institute The Johns Hopkins University School of Medicine.
Phase IIIb Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration PIER Study Year 1 Regillo CD,
OPHTHALMOLOGY DIABETES
Chronic Visual Loss. CHRONIC VISUAL LOSS 1. Measure intraocular pressure with a tonometer 2. Evaluate the nerve head 3. Evaluate the clarity of the lens.
FFA & ICG Ewan McCallum GHH 15/7/14. Overview FFA & ICG – Background – Examples – Background – Examples.
RAP Retinal angiomatous proliferation Edi LadavacGeneral Hospital Pula.
Acute choroidal ischemia and Toxoplasmic Retinochoroiditis Acute choroidal ischemia and Toxoplasmic Retinochoroiditis Sonia Attia, MD Imen Ksiaa, MD Moncef.
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Solitary Idiopathic Choroiditis: The Richard B. Weaver.
Canadian Association of Optometrists Age-Related Macular Degeneration (AMD)
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Single-Nucleotide Polymorphisms and Age-Related Macular Degeneration Maguire MG,
OCT interpretation What not to do with multifocal lenses
Macular Degeneration Chaminda Unantenne RN,MS,MSN  
Old Fibrotic Vascular tissue in End-Stage Proliferative Retinopathy
FUNDUS FLUORESCEIN ANGIOGRAPHY
CATT objectives To determine whether off-lable “Avastin” works as well as approved medication for neovascular AMD- “Lucentis” To evaluate how often treatment.
MACULAR DEGENERATION AND HEREDITARY RETINAL DYSTROPHIES
CERA Age-related macular degeneration- (AMD) information forum
A 73 years old male decrese of his VA(OD)
가톨릭대학교 의과대학 안과 및 시과학 교실 R3 장동진 / Pf.이원기
DIABETIC RETINOPATHY Süleyman ÖZEN.
Volume 1, Issue 1, Pages (January 2017)
Ocular injuries secondary to alexandrite laser-assisted hair removal
Age Related macular degeneratIon-ClassIfIcatIon
당뇨황반부종에서의 레이저 치료 의정부 성모병원 안과 양지욱.
AGE-RELATED MACULAR DEGENERATION (AMD)
Copyright © 2006 American Medical Association. All rights reserved.
3. Background diabetic retinopathy
HEREDITARY RETINAL DYSTROPHIES
Copyright © 2009 American Medical Association. All rights reserved.
OTHER ACQUIRED MACULOPATHIES
Akbar Etesam Por MD VITRORETINAL FLOWSHIP
JAMA Ophthalmology Journal Club Slides: Validity of the Age-Related Eye Disease Study Grading Scale Vitale S, Clemons TE, Agrón E, et al; Age-Related Eye.
Choroidal Neovascular
Inflammatory choroidal neovascularization
A 73 years old male decrese of his VA(OD)
January 16, 2019.
AMD update Macular research.
Indocyanine green angiography (ICG) and fluorescein angiography (FA) of the right eye (case 8). Indocyanine green angiography (ICG) and fluorescein angiography.
Presentation transcript:

OPHTHALMOLOGY MACULA DEGENERATION MBChB 4 Prof P Roux 2012

AGE-RELATED MACULAR DEGENERATION (AMD) 1. Drusen 2. Drusen and AMD 3. Atrophic AMD 4. Exudative AMD Pigment epithelial detachment (PED) Choroidal neovascularization (CNV)

Drusen Histopathology Small well-defined spots Usually innocuous Larger, ill-defined spots May enlarge and coalesce SoftHard Increased risk of AMD

FA of drusen Amount of staining Lipid content Degree of hyperfluorescence depends on: Extent of overlying RPE atrophy (window defect) ``

Drusen and AMD - progression Atrophic AMD Exudative AMD

Atrophic AMD Initially drusen and non-specific RPE changes Late RPE (geographic) atrophy Progression

Atrophic AMD Hyperfluorescence from RPE window defect Low-vision aids if appropriate ManagementFluorescein angiogram

Signs of Pigment epithelial detachment Sub-RPE fluid may be clear or turbid Circumscribed, dome-shaped elevation

FA of pigment epithelial detachment Early, well-defined hyperfluorescence Progressive increase in hyperfluorescence No increase in size of lesion

ICG angiogram of pigment epithelial detachment Later, thin surrounding hyperfluorescent ring No increase in size of lesion Early, well-defined hypofluorescence

Possible subsequent course of PED Spontaneous resolutionGeographic atrophy CNV RPE rip

Choroidal neovascularization (CNV) Metamorphopsia is initial symptom Most lesions are not visible clinically Suspicious clinical signs Pinkish-yellow subretinal lesion with fluid Subretinal blood or lipid Less common than atrophic AMD but more serious

Extrafoveal > 200  m from centre of FAZ Juxtafoveal < 200  m from centre of FAZ Angiographic classification of CNV Well-defined (classical) Subfoveal - involving centre of FAZ Poorly defined Obscured by PED, blood or exudate Occult

Late staining FA of classical CNV Leakage into subretinal space and around CNV Very early ‘lacy’ filling pattern

CNV is hyperfluorescent (hot spot) PED is hypofluorescent ICG angiogram in PED with occult CNV

Subretinal (disciform) scarring Massive subretinal exudation Possible subsequent course of CNV Haemorrhagic sensory and RPE detachment Exudative retinal detachment

Potential indications for laser treatment of CNV Classic extrafoveal CNV on FA Occult extrafoveal CNV on ICG Pre-treatment FA of classic CNV

Perimeter is treated with overlapping 200  m ( sec) burns Entire area is covered with high energy burns Technique of laser photocoagulation of CNV Lack of leakage following successful treatment Late staining around margin is normal

Treatment Anti VEGF intravitreal injection monthly x3 – Avastin – Lucentis Triamcinolone intravitreal injection every 3-6 months

Amsler grid for follow up

Amsler grid

Prevention for patients with Drusen Anti oxidants, vitamins and minerals Ocuvite with Lutein Eye Rx Healthy diet of veggies and fruits Stop smoking Treat hypercholesterolemia

Prevention for general public Healthy diet of veggies and fruits Stop smoking Treat hypercholesterolemia